Comparing desferrioxamine and light fractionation enhancement of ALA-PpIX photodynamic therapy in skin cancer

BACKGROUND: Aminolevulinic acid (ALA)-based photodynamic therapy (PDT) provides selective uptake and conversion of ALA into protoporphyrin IX (PpIX) in actinic keratosis and squamous cell carcinoma, yet large response variations in effect are common between individuals. The aim of this study was to...

Descripción completa

Detalles Bibliográficos
Autores principales: de Souza, Ana Luiza Ribeiro, Marra, Kayla, Gunn, Jason, Samkoe, Kimberley S, Kanick, Stephen Chad, Davis, Scott C, Chapman, M Shane, Maytin, Edward V, Hasan, Tayyaba, Pogue, Brian W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5046214/
https://www.ncbi.nlm.nih.gov/pubmed/27575852
http://dx.doi.org/10.1038/bjc.2016.267

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5046214/
https://www.ncbi.nlm.nih.gov/pubmed/27575852
http://dx.doi.org/10.1038/bjc.2016.267

Ejemplares similares